PharmiWeb.com - Global Pharma News & Resources

Marketing - Events

Featured Events

Events

The marcus evans S&OP and IBP for Pharma & Life Science conference taking place on 23-25 March, 2026, in Frankfurt, Germany, will bring together senior leaders in supply chain, finance, and planning to explore how pharmaceutical and life sciences organizations are transforming S&OP/IBP to accelerate decision-making, enhance planning accuracy, and strengthen business alignment. Key Topics Include:  Transform S&OP into IBP to Connect Strategy, Finance, and Execution Cross Functional Collaboration – Key for Successful S&OP/IBP Balance Short- and Long-Term Planning to Enable Strategic Alignment Leverage AI and Data to Strengthen S&OP and IBP Foundations Drive Change Management to Advance S&OP and IBP Maturity Align Portfolio and Demand to Build a Single Planni…
S&OP and IBP for Pharma & Life Science
To,    I have reached out to you as your research areas/products/services are related to our upcoming conference. Considering the same, our organizing committee would like to invite to be a part of it and you will be a great fit for our upcoming “World Congress on Advances in Applied Science and Engineering” held during 25-26 March 2026. at London, United Kingdom   The WASE 2026 aims to bring together leading researchers, academicians, industry professionals, and policymakers to share innovations, exchange ideas, and foster collaboration across a wide range of topics. We extend warm invitation to you and your organization to be a part of the conference as a Sponsors/Exhibitor/Speaker/Delegate.   Let me know your interest in the same, accordingly I will share y…
World Congress on Advances in Applied Science and Engineering
The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…
17th Edition Strategic Alliance Management for Pharma
The Marcus Evans 17th Edition Strategic Alliance Management for Pharma conference taking place in Barcelona, Spain on 21-23 April, 2026, will explore how to build resilient partnerships that deliver measurable value, leveraging both human and AI-driven capabilities. It will bring together leading pharma and biotech companies to discuss how alliances are evolving across the full partnership lifecycle - from deal negotiation to execution, governance, and value creation. It wll focus as well on the rapidly evolving environment shaped by AI adoption, global market shifts, cultural dynamics, and new partnership models. Attending this premier Marcus Evans conference will enable you to: Establish Effective Governance and Decision-making Process within the Alliance Navigating Data Management from…
17th Edition Strategic Alliance Management for Pharma
It is my distinct pleasure to welcome you to the Global Summit on Artificial Intelligence 2026 (GSAI 2026), hosted here in Singapore—one of the world’s leading hubs of innovation and technology. Under the theme “Shaping the Future,” this summit provides a global platform for thought leaders, researchers, policymakers, and industry pioneers to exchange insights on the evolving landscape of artificial intelligence. Over the next two days, we will explore how AI continues to transform economies, enhance societal well-being, and redefine the boundaries of what is possible. GSAI 2026 aims to foster meaningful dialogue on the responsible development and deployment of AI technologies—balancing innovation with ethics, progress with inclusivity, and advancement with accountability. Together, we hav…